AMPHASTAR PHARMACEUTICALS IN (AMPH)
US03209R1032 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to AMPH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 58.91. This target is 50.5% above the current price.
AMPH was analyzed by 12 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about AMPH.
In the previous month the buy percentage consensus was at a similar level.
AMPH was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-22 | Wells Fargo | Initiate | Overweight |
| 2024-08-08 | Needham | Reiterate | Hold |
| 2024-08-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-06-27 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-05-22 | Needham | Reiterate | Hold |
| 2024-05-09 | Needham | Reiterate | Hold |
| 2024-04-10 | Needham | Reiterate | Hold |
| 2024-03-05 | JP Morgan | Initiate | Overweight |
| 2023-11-17 | B of A Securities | Initiate | Neutral |
| 2023-07-25 | Jefferies | Reiterate | Buy -> Buy |
| 2023-05-17 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2022-10-25 | Piper Sandler | Maintains | Overweight |
| 2022-07-29 | Capital One | Initiate | Overweight |
| 2022-03-11 | Piper Sandler | Maintains | Overweight |
| 2022-01-07 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2021-03-17 | Wells Fargo | Maintains | Equal-Weight |